M&A Deal Summary

Alvogen Acquires LaborMed Pharma

On December 31, 2012, Alvogen acquired life science company LaborMed Pharma from Advent International and Syntaxis Capital

Acquisition Highlights
  • This is Alvogen’s 3rd transaction in the Life Science sector.
  • This is Alvogen’s 1st transaction in Romania.

M&A Deal Summary

Date 2012-12-31
Target LaborMed Pharma
Sector Life Science
Buyer(s) Alvogen
Sellers(s) Advent International
Syntaxis Capital
Deal Type Add-on Acquisition

Target

LaborMed Pharma

Ljubljana, Romania
LaborMed Pharma is a manufacturer and distributor generic pharmaceuticals primarily for cardiovascular and central nervous system aliments. The Company has also launched a portfolio of drugs for diabetes. LaborMed Pharma is based in Ljubljana, Romania.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Alvogen

Pine Brook, New Jersey, United States

Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing, and distributing generic, brand, over-the-counter brands (OTC), and biosimilar products. Alvogen was founded in 2009 and is based in Pine Brook, New Jersey.


DEAL STATS #
Overall 3 of 8
Sector: Life Science M&A 3 of 8
Type: Add-on Acquisition M&A Deals 1 of 3
Country: Romania M&A 1 of 1
Year: 2012 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-18 Kunwha Pharmaceuticals Co.

Seoul, South Korea

Kunwha Pharmaceuticals Co. Ltd. i s a manufacturer and distributor of prescription medicine.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-06 Dream Pharma

Seoul, South Korea

Dream Pharma Corp. is a generic pharmaceutical company.

Buy $187M

Seller(S) 2

SELLER

Advent International

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1984
PE ASSETS 91.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 134 of 233
Sector: Life Science M&A 9 of 13
Type: Add-on Acquisition M&A Deals 54 of 87
Country: Romania M&A 4 of 7
Year: 2012 M&A 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-01 Douglas

Hagen, Germany

Douglas is a premium beauty retailer with about 2,400 stores and fast-growing online shops in 21 European countries. Douglas has a portfolio of some 38,000 high-quality products in the areas of perfumery, decorative cosmetics and skincare. Douglas was founded in 1910 and is based in Hagen, Germany.

Buy $1.9B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-24 NCS Multistage

Houston, Texas, United States

NCS Multistage is a developer and marketer of coiled-tubing fracturing tools for the coalbed methane gas market. NCS Multistage was founded in 2006 and is based in Houston, Texas.

Buy -
SELLER

Syntaxis Capital

Vienna, Austria

Investor Investor Investor Investor Investor


Category Mezzanine Finance Firm
Founded 2006
PE ASSETS 250M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Syntaxis Capital is a private debt investor dedicated to providing long term capital to fast-growing medium-sized companies in Central Europe. It looks to invests in companies with an enterprise value of €50 - €300 million. Types of transactions include buyouts, growth capital, and consolidations. Syntaxis Capital was formed in 2006 and is based in Vienna, Austria with additional office in Warsaw, Guernsey.


DEAL STATS #
Overall 1 of 10
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 7
Country: Romania M&A 1 of 1
Year: 2012 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-01 Home.pl Sp. z o.o.

Szczecin, Poland

Home.Pl is a provider of server hosting and domain registration services in Poland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-01 Punkta Brokers

Gdansk, Poland

Punkta Brokers is an end-to-end insurance platform facilitating motor insurance. Punkta connects end users, predominantly from the SME / corporate sector, to the motor insurance market with a focus on sourcing the best pricing and protection. The offering is underpinned by Punkta's unique platform, which has capabilities across the insurance cycle, incorporating in-life claims, policy, and vehicle repair management. Punkta Brokers was founded in 1999 and is based in Gdansk, Poland.

Buy -